| Bioactivity | iRGD-CPT is a conjugate of iRGD and camptothecinthat is covalently coupled through a heterobifunctional linker. iRGD-CPT hasanticancer activity in vitroandin vivo.iRGD-CPT can be used for the study of colon cancer[1]. |
| Name | iRGD-CPT |
| Formula | C75H100N18O27S3 |
| Molar Mass | 1781.90 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Singh,Tejinder et al. Tumor-homing peptide iRGD-conjugate enhances tumor accumulationof camptothecin for colon cancer therapy. European journal of medicinalchemistry, vol. 265 116050. 16 Dec. 2023 |